Papillary thyroid cancer (PTC) is a common endocrine system malignancy all over the world.
Aberrant expression of six transmembrane epithelial antigen of the prostate 2 (STEAP2) has …

N6 methyladenosine (m6A) modification serves as a novel epigenetic regulatory mechanism
that is heavily implicated in the heredity of tumors. Meanwhile, fat mass and obesity …

Growing evidence indicates that N6-methyladenosine (m 6 A) is the most pervasive RNA
modification in eukaryotic cells. However, the specific role of METTL3 in papillary thyroid …

Abstract N6-methyladenine (m6A) is the most predominant RNA modification, which has
been shown to be related to many types of cancers. However, understanding of its role in …

Background Papillary thyroid cancer (PTC) is the most common type of cancer of the
endocrine system. Long noncoding RNAs (lncRNAs) are emerging as a novel class of gene …

Objective This study aims to uncover the progression of thyroid carcinoma influenced by the
m6A methyltransferase METTL3 through regulating m6A methylation on TCF1 mRNA and …

Papillary thyroid carcinoma (PTC) is one of the most common kinds of endocrine-related
cancer and has a heterogeneous prognosis. Metabolic reprogramming is one of the …

Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is overexpressed in
numerous types of tumors, especially in prostate cancer. STEAP1 is located in the plasma …

STEAP3 (Six-transmembrane epithelial antigen of the prostate 3, TSAP6, dudulin-2) has
been reported to be involved in tumor progression in human malignancies. Nevertheless …

Purpose N6-methyladenosine (m6A) is the most abundant internal modification on
eukaryotic mRNA and gained increasing attention recently. More and more evidence …